Personally, I think that risk is actually overblown and is more of a theoretical risk, but we certainly adhere to that, so we dont prescribe it to this very select population, but thats something a physician and a patient will talk about. Are physicians concerned about the drug being used by patients with eating disorders
This comprehensive test analyzes various genetic markers to reveal how your body processes nutrients, responds to different types of exercise, and reacts to specific medications
One of the things that is hotly debated, even when youre talking about CPAP use, and this is a little bit different even from the pediatric lens, is that when we modify OSA, do we cause weight loss or weight gain
gavage (4 mL/kg) together with the glucose bolus during OGTT and the appearance of acetaminophen in plasma was measured after 30 min
The message to the patient is that we are still investigating if these drugs put them at higher risk of ischemic optic nerve damage
We can support better patient outcomes by: Screening for obesity-related risks and identifying patients who may benefit from metabolic therapy